Literature DB >> 21277686

What is a functional locus? Understanding the genetic basis of complex phenotypic traits.

Edward A Ruiz-Narváez1.   

Abstract

A multitude of results from genome-wide association studies have been published in recent years in relation to different human diseases and phenotypic traits. However, the identified polymorphisms explain just a small fraction of the variability of the traits and they are poor predictors of occurrence of disease. Although part of the missing variability may be found in still to be identified rare genetic variants, the present work proposes that a major part of the problem is due to our conceptual limitations regarding functional loci and its variants. Functional variants are currently defined in absolute positional terms; they are just sequence variations in fixed positions along the DNA molecule. In the present study is postulated that functional loci may include different positions in the DNA sequence. As consequence, variants of the same functional locus may be located in different physical positions along the genome and, the observed effect of any particular genetic variant will be then reduced compared to its true effect. The differential use of regulatory regions such as gene promoters and enhancers would be a particular case of the proposed hypothesis. The hypothesis makes predictions that can be tested, offering potential paths of research to elucidate the genetic basis of complex human traits.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21277686      PMCID: PMC3076543          DOI: 10.1016/j.mehy.2011.01.019

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  47 in total

1.  Are rare variants responsible for susceptibility to complex diseases?

Authors:  J K Pritchard
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

2.  The organization, promoter analysis, and expression of the human PPARgamma gene.

Authors:  L Fajas; D Auboeuf; E Raspé; K Schoonjans; A M Lefebvre; R Saladin; J Najib; M Laville; J C Fruchart; S Deeb; A Vidal-Puig; J Flier; M R Briggs; B Staels; H Vidal; J Auwerx
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

3.  Performance of common genetic variants in breast-cancer risk models.

Authors:  Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; Stephen J Chanock; David J Hunter
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

4.  High frequency of antigenic variation in Trypanosoma brucei rhodesiense infections.

Authors:  C M Turner; J D Barry
Journal:  Parasitology       Date:  1989-08       Impact factor: 3.234

5.  The uncoupling protein-3 gene is transcribed from tissue-specific promoters in humans but not in rodents.

Authors:  H Esterbauer; H Oberkofler; F Krempler; A D Strosberg; W Patsch
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

6.  Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3.

Authors:  W B Archey; M P Sweet; G C Alig; B A Arrick
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

7.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Authors:  R Dammann; C Li; J H Yoon; P L Chin; S Bates; G P Pfeifer
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

8.  The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter.

Authors:  Andrea Ventura; Lucilla Luzi; Sonia Pacini; Cosima T Baldari; Pier Giuseppe Pelicci
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

9.  The human connexin32 gene is transcribed from two tissue-specific promoters.

Authors:  I M Neuhaus; L Bone; S Wang; V Ionasescu; R Werner
Journal:  Biosci Rep       Date:  1996-06       Impact factor: 3.840

10.  Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads.

Authors:  S E Bulun; I M Rosenthal; A M Brodie; S E Inkster; W P Zeller; A M DiGeorge; S D Frasier; M W Kilgore; E R Simpson
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

View more
  4 in total

1.  Redundant enhancers and causal variants in the TCF7L2 gene.

Authors:  Edward A Ruiz-Narváez
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

2.  Identifying Multi-Omics Causers and Causal Pathways for Complex Traits.

Authors:  Huaizhen Qin; Tianhua Niu; Jinying Zhao
Journal:  Front Genet       Date:  2019-02-21       Impact factor: 4.599

3.  Use of alternative promoters may hide genetic effects on phenotypic traits.

Authors:  Edward A Ruiz-Narváez
Journal:  J Hum Genet       Date:  2012-10-04       Impact factor: 3.172

Review 4.  Is atypical rhythm a risk factor for developmental speech and language disorders?

Authors:  Enikő Ladányi; Valentina Persici; Anna Fiveash; Barbara Tillmann; Reyna L Gordon
Journal:  Wiley Interdiscip Rev Cogn Sci       Date:  2020-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.